A Win For Kinnate Biopharma Inc.

Mon, Mar 13, 2023 at 07:10 PM

Kinnate Biopharma Inc. (KNTE:NASDAQ) shot up at $4.32, a gain of 24.9%. The stock appeared on our News Catalysts scanner on Tue, Feb 21, 2023 at 04:38 PM in the 'BIOTECH' category. From Mon, Feb 27, 2023, the stock recorded 20.00% Up Days and 27.27% Green Days

About Kinnate Biopharma Inc. (KNTE:NASDAQ)

Kinnate Biopharma Inc a biopharmaceutical company focused on the discovery and development of small molecule kinase inhibitors for difficult-to-treat, genomically defined cancers.

Top 10 Gainers:

Provention Bio, Inc. (PRVB:NASDAQ), 259.7%
Cipher Mining Inc. (CIFR:NASDAQ), 37.88%
Euda Health Holdings Ltd Ord Shs (EUDA:NASDAQ), 36.63%
Calliditas Therapeutics AB (CALT:NASDAQ), 31.9%
Reborn Coffee Inc. (REBN:NASDAQ), 30.41%
Antelope Enterprise Holdings Limited (AEHL:NASDAQ), 29.56%
Hycroft Mining Holding Corporation (HYMC:NASDAQ), 28.74%
Marathon Patent Group, Inc. (MARA:NASDAQ), 25.7%
Ault Alliance Inc Com (AULT:NYSEMKT), 24.86%
Kinnate Biopharma Inc. (KNTE:NASDAQ), 24.86%